Publication List 2011

1984-94, 1995, 1996, 1997, 1998, 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022

19
（379）		 Kaneda A, Fujita T, Anai M, Yamamoto S, Nagae G, Morikawa M, Tsuji S, Oshima M, Miyazono K, Aburatani H.
Activation of Bmp2-Smad1 signal and its regulation by coordinated alteration of H3K27 trimethylation in Ras-induced senescence.
PLoS Genet. 2011 Nov;7(11):e1002359.
18
（378）		 Suzuki HI, Arase M, Matsuyama H, Choi YL, Ueno T, Mano H, Sugimoto K, Miyazono K.
MCPIP1 ribonuclease antagonizes dicer and terminates microRNA biogenesis through precursor microRNA degradation.
Mol Cell. 2011 Nov 4;44(3):424-36.
17
（377）		 Matsuyama H, Suzuki HI, Nishimori H, Noguchi M, Yao T, Komatsu N, Mano H, Sugimoto K, Miyazono K.
miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma.
Blood. 2011 Dec 22;118(26):6881-92.
16
（376）		 Cabral H, Matsumoto Y, Mizuno K, Chen Q, Murakami M, Kimura M, Terada Y, Kano MR, Miyazono K, Uesaka M, Nishiyama N, Kataoka K.
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size.
Nat Nanotechnol. 2011 Oct 23;6(12):815-23.
15
（375）		 Shirai YT, Ehata S, Yashiro M, Yanagihara K, Hirakawa K, Miyazono K.
Bone morphogenetic protein-2 and -4 play tumor suppressive roles in human diffuse-type gastric carcinoma.
Am J Pathol. 2011 Dec;179(6):2920-30.
14
（374）		 Ikushima H, Todo T, Ino Y, Takahashi M, Saito N, Miyazawa K, Miyazono K.
Glioma-initiating cells retain their tumorigenicity through integration of the Sox axis and Oct4 protein.
J Biol Chem. 2011 Dec 2;286(48):41434-41.
13
（373）		 Yoshimatsu Y, Yamazaki T, Mihira H, Itoh T, Suehiro J, Yuki K, Harada K, Morikawa M, Iwata C, Minami T, Morishita Y, Kodama T, Miyazono K, Watabe T.
Ets family members induce lymphangiogenesis through physical and functional interaction with Prox1.
J Cell Sci. 2011 Aug 15;124(Pt 16):2753-62.
12
（372）		 Koinuma D, Shinozaki M, Nagano Y, Ikushima H, Horiguchi K, Goto K, Chano T, Saitoh M, Imamura T, Miyazono K, Miyazawa K.
RB1CC1 protein positively regulates transforming growth factor-beta signaling through the modulation of Arkadia E3 ubiquitin ligase activity.
J Biol Chem. 2011 Sep 16;286(37):32502-12.
11
（371）		 Morikawa M, Koinuma D, Tsutsumi S, Vasilaki E, Kanki Y, Heldin CH, Aburatani H, Miyazono K.
ChIP-seq reveals cell type-specific binding patterns of BMP-specific Smads and a novel binding motif.
Nucleic Acids Res. 2011 Nov 1;39(20):8712-27.
10
（370）		 Watanabe A, Ogiwara H, Ehata S, Mukasa A, Ishikawa S, Maeda D, Ueki K, Ino Y, Todo T, Yamada Y, Fukayama M, Saito N, Miyazono K, Aburatani H.
Homozygously deleted gene DACH1 regulates tumor-initiating activity of glioma cells.
Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12384-9.
9
（369）		 Mizutani A, Koinuma D, Tsutsumi S, Kamimura N, Morikawa M, Suzuki HI, Imamura T, Miyazono K, Aburatani H.
Cell type-specific target selection by combinatorial binding of Smad2/3 proteins and hepatocyte nuclear factor 4α in HepG2 cells.
J Biol Chem. 2011 Aug 26;286(34):29848-60.
8
（368）		 Ikushima H, Miyazono K.
Biology of transforming growth factor-β signaling.
Curr Pharm Biotechnol. 2011 Dec;12(12):2099-107.
7
（367）		 Miyazono K.
Molecular mechanisms of transforming growth factor-β signaling and disease: The 59th Fujihara International Seminar, 2010.
Cancer Sci. 2011 Jun;102(6):1242-4.
6
（366）		 Takahashi S, Watanabe T, Okada M, Inoue K, Ueda T, Takada I, Watabe T, Yamamoto Y, Fukuda T, Nakamura T, Akimoto C, Fujimura T, Hoshino M, Imai Y, Metzger D, Miyazono K, Minami Y, Chambon P, Kitamura T, Matsumoto T, Kato S.
Noncanonical Wnt signaling mediates androgen-dependent tumor growth in a mouse model of prostate cancer.
Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4938-43.
5
（365）		 Shirakihara T, Horiguchi K, Miyazawa K, Ehata S, Shibata T, Morita I, Miyazono K, Saitoh M.
TGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transition.
EMBO J. 2011 Feb 16;30(4):783-95.
4
（364）		 Ehata S, Johansson E, Katayama R, Koike S, Watanabe A, Hoshino Y, Katsuno Y, Komuro A, Koinuma D, Kano MR, Yashiro M, Hirakawa K, Aburatani H, Fujita N, Miyazono K.
Transforming growth factor-β decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells.
Oncogene. 2011 Apr 7;30(14):1693-705.
3
（363）		 Miyazono K, Koinuma D.
Arkadia--beyond the TGF-β pathway.
J Biochem. 2011 Jan;149(1):1-3.
2
（362）		 Hoshino Y, Katsuno Y, Ehata S, Miyazono K.
Autocrine TGF-β protects breast cancer cells from apoptosis through reduction of BH3-only protein, Bim.
J Biochem. 2011 Jan;149(1):55-65.
1
（361）		 Suzuki HI, Miyazono K.
Emerging complexity of microRNA generation cascades.
J Biochem. 2011 Jan;149(1):15-25.